These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29721701)

  • 1. Potable Water Reuse: What Are the Microbiological Risks?
    Nappier SP; Soller JA; Eftim SE
    Curr Environ Health Rep; 2018 Jun; 5(2):283-292. PubMed ID: 29721701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Predicted Microbiological Human Health Risks Associated with de Facto, Indirect, and Direct Potable Water Reuse.
    Soller JA; Eftim SE; Nappier SP
    Environ Sci Technol; 2019 Nov; 53(22):13382-13389. PubMed ID: 31577425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drivers of Microbial Risk for Direct Potable Reuse and de Facto Reuse Treatment Schemes: The Impacts of Source Water Quality and Blending.
    Chaudhry RM; Hamilton KA; Haas CN; Nelson KL
    Int J Environ Res Public Health; 2017 Jun; 14(6):. PubMed ID: 28608808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying pathogen risks associated with potable reuse: A risk assessment case study for Cryptosporidium.
    Amoueyan E; Ahmad S; Eisenberg JNS; Pecson B; Gerrity D
    Water Res; 2017 Aug; 119():252-266. PubMed ID: 28475966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogen reduction requirements for direct potable reuse in Antarctica: evaluating human health risks in small communities.
    Barker SF; Packer M; Scales PJ; Gray S; Snape I; Hamilton AJ
    Sci Total Environ; 2013 Sep; 461-462():723-33. PubMed ID: 23770553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a fluorescence EEM-PARAFAC model for direct and indirect potable water reuse monitoring: Multi-stage ozone-biofiltration without reverse osmosis at Gwinnett County, Georgia, USA.
    Wells MJM; Funk D; Mullins GA; Bell KY
    Sci Total Environ; 2023 Aug; 886():163937. PubMed ID: 37149191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A robust scenario analysis approach to water recycling quantitative microbial risk assessment.
    Jones CH; Wylie V; Ford H; Fawell J; Holmer M; Bell K
    J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36796790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot testing of direct and indirect potable water reuse using multi-stage ozone-biofiltration without reverse osmosis.
    Hooper J; Funk D; Bell K; Noibi M; Vickstrom K; Schulz C; Machek E; Huang CH
    Water Res; 2020 Feb; 169():115178. PubMed ID: 31670085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogen infection risk to recreational water users, associated with surface waters impacted by de facto and indirect potable reuse activities.
    Purnell S; Halliday A; Newman F; Sinclair C; Ebdon J
    Sci Total Environ; 2020 Jun; 722():137799. PubMed ID: 32197157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct potable reuse microbial risk assessment methodology: Sensitivity analysis and application to State log credit allocations.
    Soller JA; Eftim SE; Nappier SP
    Water Res; 2018 Jan; 128():286-292. PubMed ID: 29107913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial and temporal variation in de facto wastewater reuse in drinking water systems across the U.S.A.
    Rice J; Westerhoff P
    Environ Sci Technol; 2015 Jan; 49(2):982-9. PubMed ID: 25544250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of De Facto Wastewater Reuse across the US: trends between 1980 and 2008.
    Rice J; Wutich A; Westerhoff P
    Environ Sci Technol; 2013 Oct; 47(19):11099-105. PubMed ID: 23957863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greywater reuse - Assessment of the health risk induced by Legionella pneumophila.
    Blanky M; Sharaby Y; Rodríguez-Martínez S; Halpern M; Friedler E
    Water Res; 2017 Nov; 125():410-417. PubMed ID: 28889040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not all information is informative: An exploration of educational content on recycled potable water knowledge and acceptance.
    Tanner B; McDonald P; Mahmoud-Elhaj D; Sabatini D; Chamberlain JF; Nijhawan A; Rainbolt-Forbes E; Feltz A
    Water Res; 2024 Mar; 252():121254. PubMed ID: 38335749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Techno-economic assessment of a novel algal-membrane system versus conventional wastewater treatment and advanced potable reuse processes: Part II.
    Lugo A; Xu X; Abeysiriwardana-Arachchige ISA; Bandara GLCL; Nirmalakhandan N; Xu P
    J Environ Manage; 2023 Apr; 331():117189. PubMed ID: 36634420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human health impact of non-potable reuse of distributed wastewater and greywater treated by membrane bioreactors.
    Schoen ME; Jahne MA; Garland J
    Microb Risk Anal; 2018 Aug; 9():72-81. PubMed ID: 35280215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tertiary treatment and dual disinfection to improve microbial quality of reclaimed water for potable and non-potable reuse: A case study of facilities in North Carolina.
    Bailey ES; Casanova LM; Simmons OD; Sobsey MD
    Sci Total Environ; 2018 Jul; 630():379-388. PubMed ID: 29482146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple barriers as an efficient treatment for removing pesticides aiming direct potable reuse: A pilot scale study.
    de Medeiros JF; Montagner CC
    Environ Pollut; 2024 Jun; 350():124009. PubMed ID: 38670423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond User Acceptance: A Legitimacy Framework for Potable Water Reuse in California.
    Harris-Lovett SR; Binz C; Sedlak DL; Kiparsky M; Truffer B
    Environ Sci Technol; 2015 Jul; 49(13):7552-61. PubMed ID: 26030335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative microbial risk assessment of a non-membrane based indirect potable water reuse system using Bayesian networks.
    Zhiteneva V; Carvajal G; Shehata O; Hübner U; Drewes JE
    Sci Total Environ; 2021 Aug; 780():146462. PubMed ID: 33774303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.